Labshake search
Citations for R&D Systems :
1 - 50 of 2547 citations for Anti Epidermis type lipoxygenase 12 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Genomics 2024Quote: ... M anti-DENV NS1 (Type 2/3/4) (Cat# MAB94441-100, R&D Systems), M anti-NXT1 (Cat#67680-1-Ig ...
-
bioRxiv - Cancer Biology 2023Quote: ... Type 2 (R&D Systems) and plated on 8-chamber slides (Thermo Scientific).
-
bioRxiv - Cancer Biology 2024Quote: ... Type 3 (R&D Systems); coenzyme Q10 (CoQ) ...
-
bioRxiv - Immunology 2024Quote: ... Type 2 (R&D Systems). 37.5μL of matrix was pipetted in the center of each well of an 8-chamber slide (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 2 (BME, R&D Systems) depending on the passaging ratio ...
-
bioRxiv - Cell Biology 2023Quote: ... type 2 (R&D Systems, #3533-001) and cultured and passaged as previously described for Chol-Orgs75 and Hep-Orgs44 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 2 (# 3533-010-02 R&D systems), or 2.5 mg/mL OmGel at a concentration of 1000 cells / µL and plated as a droplet in 48-well or 96 well plates ...
-
bioRxiv - Neuroscience 2024Quote: ... Type II (R&D Systems, 3532-010-02). The cell lines were confirmed to be free of mycoplasma.
-
bioRxiv - Biophysics 2024Quote: ... Type 2 (3533-010-02 R&D systems) and seeded on glass chamber slides in 20 μL domes and cultured in F-12 Ham Nutrient media with 1% penicillin/streptomycin ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 2 (R&D Systems, 3533-005-02).
-
bioRxiv - Biophysics 2024Quote: ... Type 2 (3533-010-02 R&D systems) and seeding on glass chamber slides in 20 μL domes ...
-
bioRxiv - Immunology 2022Quote: ... and MMP-12 (R&D Systems) were used as positive controls ...
-
bioRxiv - Microbiology 2021Quote: ... human type I IFN (R&D systems, 11415-1) was typically added at a final concentration of 150 U/ml ...
-
bioRxiv - Immunology 2024Quote: ... resuspended in BME type 2 (R&D Systems, 353300502), and cultured as previously described111 ...
-
bioRxiv - Immunology 2022Quote: ... and IL-12 (R&D Systems #M1270) were determined in spinal cord supernatants 7- and 14-days post immunisation by ELISA ...
-
bioRxiv - Immunology 2022Quote: ... 5ng/mL IL-12 (R&D Systems), 20 U/mL rhIL-2 (PeproTech) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 12 ng/ml FGF2 (R&D systems) and 20 ng/ml Activin A (PeproTech ...
-
bioRxiv - Immunology 2021Quote: ... mIL-12 (10ng/ml; R&D Systems) for TH1 cell polarization ...
-
bioRxiv - Cell Biology 2023Quote: ... containing 12 µM CHIR99021 (R&D Systems) for 24 h ...
-
bioRxiv - Bioengineering 2021Quote: ... 12 million cells were purified for CD90+ cells using a PE-conjugated antibody for anti-CD90 (R&D Systems, FAB2067P), the EasySep™ Human PE Positive Selection Kit II (STEMCELL Technologies ...
-
bioRxiv - Microbiology 2023Quote: ... or 1000U/mL universal type 1 interferon (R&D Systems) for 30 minutes ...
-
bioRxiv - Pathology 2024Quote: ... and pro-collagen type I (#DY6220-05, R&D Systems) were measured using ELISA kits ...
-
bioRxiv - Bioengineering 2024Quote: ... type 2 (BME-2; R&D Systems; 3532-010-02), and dispensed in a 24-well plate to form 50 µL BME-2 domes for culture ...
-
bioRxiv - Bioengineering 2021Quote: ... 12 million cells were then purified for CD90+ cells using a PE-conjugated antibody for anti-CD90 (R&D Systems, FAB2067P), the EasySep™ Human PE Positive Selection Kit II and EasySep™ Magnet.
-
bioRxiv - Immunology 2021Quote: ... and 500 ng/ml soluble anti-CD28 and cultured in the absence (Th0) or presence of 2.5 ng/ml IL-12 (R&D Systems) (Th1 ...
-
bioRxiv - Immunology 2021Quote: ... The cell-free supernatants derived from CD10neg/CD10pos neutrophils were added to CD4+ T-cells cultured in 96-well plates (8×104 cells/well) in the presence of neutralizing anti-IL-12 antibody (4μg/mL; MAB219, R&D Systems) or isotype control (4μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... Th1: 20ng/ml rmIL-12 (R&D systems); Th2 ...
-
bioRxiv - Immunology 2022Quote: ... IL-12 (50 ng/ml; R&D Systems) and IL-18 (50 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... and FGF2 (12 ng/ml, R&D Systems). For in vitro differentiation of EpiSC-L cells ...
-
bioRxiv - Cell Biology 2021Quote: ... proTAME (APC/Ci, R&D Systems, 12 μM), AZ-3146 (Mps1i ...
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-12 (R&D systems and Peprotech) or recombinant IL-15 (Miltenyi Biotec ...
-
bioRxiv - Immunology 2023Quote: ... 5 ng/ml IL-12 (R&D Systems) and 3 μg/ml anti-IL-4 in the presence of plate bound anti-CD3ε (1 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 (12 ng/ml; R&D Systems); all-trans retinoic acid (ATRA ...
-
bioRxiv - Neuroscience 2022Quote: ... 100µL of collagen type I solution (Corning or R&D systems, 3 mg/mL with a pH adjusted to 7.0-7.2 with NaOH ...
-
bioRxiv - Cell Biology 2022Quote: ... Type 2 (BME-2) droplets (R&D Systems, Minneapolis, MN, USA) and covered under medium ...
-
bioRxiv - Cancer Biology 2024Quote: ... type 2 (∼4mg/ml, Cultrex, RGF BME, Type2; R&D Systems) and maintained in LO complete media which consists of LO basic media -Advanced DMEM/F12 media (Thermo Fisher) ...
-
bioRxiv - Bioengineering 2024Quote: ... Rat Tail Collagen Type 1 (R&D Systems, 3447-020-01) prepared at 4 mg/mL with a 1:1:8 ratio of 3.7% (w/v ...
-
bioRxiv - Systems Biology 2024Quote: ... Type 2 (BME; R&D Systems, Minneapolis, MN; 3533-001-02) and droplets of 60μL were plated onto 24-well plates ...
-
bioRxiv - Immunology 2024Quote: ... or BME (Cultrex® RGF BME Type 2, R&D systems). GrowDex (supplied as a suspension of 1.5% nanofibrillar cellulose in 98.5% ultra-pure water ...
-
bioRxiv - Bioengineering 2022Quote: ... EC population purity was evaluated on day 12 via live-cell flow cytometry using an anti-CD31 – Alex 488 conjugated antibody (1:100, R&D Systems). Only EC populations with ≥ 90% CD31-positivity were used for this study.
-
bioRxiv - Developmental Biology 2024Quote: ... EBs from each AggreWell were transferred to an Anti-Adherence Rinsing Solution treated well of a 12-well plate in media with 10 ng/ml BMP4 (R&D Systems), 5 ng/ml FGF2 (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems) in order to promote the differentiation into plasmablasts (“2nd step differentiation cocktail”)8 ...
-
bioRxiv - Immunology 2022Quote: ... and 12 ng/ml IL-10 (R&D Systems).
-
bioRxiv - Cancer Biology 2023Quote: ... and IL-12 (10 ng/ml, R&D Systems), anti-human IL-4 (OA19A66 ...
-
bioRxiv - Immunology 2024Quote: ... IL-12 + IL-18 (20ng/ml; R&D Systems) or no cytokine for 24h ...
-
bioRxiv - Cancer Biology 2020Quote: ... wild-type mice were measured using a kit from R&D Systems according to the manufacturer’s recommendations.
-
bioRxiv - Cancer Biology 2024Quote: ... embedded in Cultrex RGF BME type 2 (∼4mg/ml, R&D Systems), and three BCS of either shWT or shERK3 were placed around the LO ...
-
bioRxiv - Immunology 2022Quote: ... 10ng/ml IL-12 (R&D systems, Minneapolis, MN, USA) and 2μg/ml anti-IL4 (Biolegend ...
-
bioRxiv - Immunology 2020Quote: ... IL-15 and IL-18 (rhIL-12, R&D Systems, 5 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... or 30ng/mL IL-12 (R&D system, Cat# 219IL005) was used to stimulated cells for 10-30min ...